• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADVANCED STERILIZATION PRODUCTS CIDEX OPA SOLUTION; BIOCIDES SOLUTIONS (MED)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADVANCED STERILIZATION PRODUCTS CIDEX OPA SOLUTION; BIOCIDES SOLUTIONS (MED) Back to Search Results
Catalog Number 20390
Medical Device Problem Code Chemical Problem (2893)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 01/14/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Brand name: the correct brand name is cidex opa solution ghs.Catalog number: the correct catalog number is 20390_93, lot # 526500021, exp 9/21/2017.
 
Event or Problem Description
A customer reported they were inadequately rinsing their instruments after cleaning and disinfecting in cidexpa solution, and the instruments were released and used on patients.No serious injuries were reported.The customer stated they were unaware of the proper rinsing procedures and were soaking their endovaginal probes in a open container with no lid, then wrapping the probe in a wash cloth and rinsing the probe in the sink.The instructions for use (ifu) states the instruments should be submerged completely into a clean, large water container for a minimum of one minute.This should be repeated twice for a total of three rinses.Failure to rinse devices per the ifu may result in patient side effects, including serious allergic reaction to residues or discoloration of tissues.The customer was advised to follow the ifu from now on.As a matter of policy, advanced sterilization products (asp) has decided to report cases of improperly rinsed instruments after using cidex opa solution since it could result in serious patient side effects.
 
Additional Manufacturer Narrative
(b)(4).Lot #: 526500021.Asp investigation summary: the investigation included a review of the visual analysis, batch record, supplier evaluation, retains testing, batch trending, trending by lot #, and system risk analysis.A visual analysis was not performed as the issue was not identified to be a manufacturing or functional issue.The batch record was reviewed and did not identify any anomalies.Supplier evaluation was not required as this was not a manufacturing or functional issue.Retain testing was not performed as this was not a manufacturing or functional issue.Complaint trending by lot # was reviewed and did not identify a trend.The system risk analysis (sra) was reviewed for the issue of procedure related and the risk was determined to be "low risk." the assignable cause is failure to follow instructions.The customer was not properly rinsing their instruments according to the instructions for use (ifu).A customer letter will be sent providing further information on proper rinsing and instructions for use.Asp will continue to track and trend this issue.No further investigation is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CIDEX OPA SOLUTION
Common Device Name
BIOCIDES SOLUTIONS (MED)
Manufacturer (Section D)
ADVANCED STERILIZATION PRODUCTS
33 technology drive
irvine CA 92618
MDR Report Key5397724
Report Number2084725-2016-00053
Device Sequence Number198983
Product Code MED
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K991487
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/21/2017
Device Catalogue Number20390
Other Device ID Number20390
Was Device Available for Evaluation? No
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 01/14/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date01/28/2016
Supplement Report FDA Received Date02/23/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-